Hillhouse

To add a bio or update investment portfolio, please click update information.

Investment Portfolio

Tenpoint Therapeutics unlocks a £170m Series B from investors to rejuvenate vision in the aging eye

29 Jan 2026

Tenpoint Therapeutics unlocks a £170m Series B from investors to rejuvenate vision in the aging eye

Tenpoint Therapeutics develops treatments for age-related eye conditions. Its products are designed to address presbyopia and other vision issues through clinically developed ophthalmic therapies.

Hillhouse

- Life Sciences
1(12 months)
hillhouseinvestment.com
Update Information

More venture news

Partly
24 Jun 2026
Partly lands £40m Series B led by DST Global Partners for its AI foundation model for the automotive repair supply chain
Series BSupply Chain
Wordsmith AI
3 Jun 2026
Wordsmith raises £55m Series B from Highland Europe and Index Ventures to bring end-to-end operations platform to in-house legal teams
Series BLegal
Orbital Industries
28 May 2026
Orbital Industries lands £37m Series B led by Plural to build data centre hardware with AI model
Series BAI

Hillhouse

Investment Portfolio

Tenpoint Therapeutics unlocks a £170m Series B from investors to rejuvenate vision in the aging eye

More venture news

Partly lands £40m Series B led by DST Global Partners for its AI foundation model for the automotive repair supply chain

Wordsmith raises £55m Series B from Highland Europe and Index Ventures to bring end-to-end operations platform to in-house legal teams

Orbital Industries lands £37m Series B led by Plural to build data centre hardware with AI model